Vimseltinib
规格
1628606-05-2CAS 号
3-methyl-5-[6-methyl-5-[[2-(1-methylpyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-(propan-2-ylamino)pyrimidin-4-oneIUPAC 名称
C23H25N7O2化学式
431.5 g/mol分子量
Vimseltinib; DCC-3014; 2-(isopropylamino)-3-methyl-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)pyrimidin-4(3H)-one; Vimseltinib [INN]; Vimseltinib [USAN]; DP-6865; PX9FTM69BF; DCC3014; UNII-PX9FTM69BF; VIMSELTINIB [WHO-DD]; 3-methyl-5-[6-methyl-5-[2-(1-methylpyrazol-4-yl)pyridin-4-yl]oxypyridin-2-yl]-2-(propan-2-ylamino)pyrimidin-4-one; compound 20 [PMID: 35961460]; example 10 [WO2014145025A2]; 3-Methyl-2-((1-methylethyl)amino)-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl)oxy)-2-pyridinyl)-4(3H)-pyrimidinone; 4(3H)-Pyrimidinone, 3-methyl-2-((1-methylethyl)amino)-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl)oxy)-2-pyridinyl)-; compound 20 (PMID: 35961460); example 10 (WO2014145025A2); 3-methyl-5-(6-methyl-5-(2-(1-methylpyrazol-4-yl)pyridin-4-yl)oxypyridin-2-yl)-2-(propan-2-ylamino)pyrimidin-4-one; RefChem:194257; CSF1R Inhibitor DCC-3014; DCC 3014; 1628606-05-2; ROMVIMZA; MFCD32858282; Vimseltinib (USAN/INN); Vimseltinib [USAN:INN]; DCC-3014(Vimseltinib)?; orb1309886; orb1940816; CHEMBL5095202; SCHEMBL16047448; SCHEMBL30453793; GTPL11190; YQF2536; TVGAHWWPABTBCX-UHFFFAOYSA-N; DTXSID301376677; EX-A4700; BDBM50589669; NSC828316; WHO 11443; AKOS040732693; EBC-415078; NSC-828316; AC-37103; DA-72595; MS-27682; HY-136256; CS-0121044; D12238; G17514; T10652; 2-(isopropylamino)-3-methyl-5-[6-methyl-5-[[2-(1-methylpyrazol-4-yl)-4-pyridyl]oxy]-2-pyridyl]pyrimidin-4-one; 3-methyl-5-(6-methyl-5-{[2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl]oxy}pyridin-2-yl)-2-[(propan-2-yl)amino]pyrimidin-4(3H)-one; Z6V同义词